 Subjects undergoing bilateral SLT will be randomly assigned to use prednisolone acetate 1 in one eye four times daily with no treatment in the fellow eye, for one week following SLT. Examinations will occur at baseline, and one week, one month and three months after SLT. IOP and anterior chamber inflammation will be noted at each visit. 